Read the Official PANTHERx Press Release. PANTHERx® Rare Pharmacy announces that it has been selected by Deciphera Pharmaceuticals as a limited distribution partner for new drug QINLOCKTM (ripretinib). QINLOCK™ is …
Read the Official PANTHERx Press Release. PANTHERx Rare Pharmacy (PANTHERx) has again been recognized as the winner of the annual, national Specialty Pharmacy Patient Choice Award™. “We are honored and …
Read the Official PANTHERx Press Release. In a landmark, non-commercial publication available for download, PANTHERx Rare Pharmacy explores the details of how changes in U.S. Federal policy and advances in …
PANTHERx Rare Pharmacy earns a spot on exclusive list as a Top 10 Specialty Pharmacy of 2019 as reported by Adam Fein, Ph.D., CEO of Drug Channels Institute. The list, …
Dr. Gordon Vanscoy, Chairman and CEO of PANTHERx Rare Pharmacy and RareMed Solutions, is honored to be headlining the April 2020 cover of Smart Business Magazine. The magazine features an …
A lot has changed since PANTHERx released our first public statement nearly a month ago and we have been incredibly busy staying ahead of the curve. In Pennsylvania (home to …
At PANTHERx we often have the pleasure of getting to know not only our patients but also their families. Parents, children, and siblings can serve as caregivers and support to …
This year, the highly respected Journal of Managed Care & Specialty Pharmacy (JMCP) celebrates its 25th anniversary. To mark this milestone, they are publishing a series of landmark articles documenting …
PANTHERx Rare Pharmacy is proud to have again earned the #1 ranking in the quarterly patient satisfaction survey conducted by Zitter Health Insights, an independent national survey entity. For the …
The leadership at PANTHERx Rare has been closely monitoring the ongoing developments related to the concerns arising from the impact of Coronavirus (COVID-19). Nothing is more important to us than …
